ScholarIQanswers from OpenAlex & ORCID
Bruce L. Levine
ResearcherPublications, citations & collaboration network
Bruce L. Levine is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bruce L. Levine have?
ScholarIQindexed works
Bruce L. Levine has 541 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bruce L. Levine have?
ScholarIQcitation count
Bruce L. Levine has 67,975 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bruce L. Levine?
ScholarIQh-index
Bruce L. Levine has an h-index of 102 in OpenAlex.
What is the i10-index of Bruce L. Levine?
ScholarIQi10-index
Bruce L. Levine has an i10-index of 252 in OpenAlex.
What is the ORCID of Bruce L. Levine?
ScholarIQorcid
The ORCID for Bruce L. Levine is on the source record.
What is the OpenAlex record for Bruce L. Levine?
ScholarIQopenalex
The OpenAlex for Bruce L. Levine is on the source record.
What are the most-cited papers on Bruce L. Levine?
ScholarIQmost cited works
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R. Verneris, Heather E. Stefanski, Gary D. Myers, Muna Qayed, Barbara De Moerloose, Hidefumi Hiramatsu, Krysta Schlis, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Gregory A. Yanik, Christina Peters, André Baruchel, Nicolas Boissel, Françoise Méchinaud, Adriana Balduzzi, Joerg Krueger, Carl H. June, Bruce L. Levine, Patricia A. Wood, Tetiana Taran, Mimi Leung, Karen T. Mueller, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Michael A. Pulsipher, Stephan A. Grupp
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl, Olga Goloubeva, Dan T. Vogl, Simon F. Lacey, Ashraf Badros, Alfred L. Garfall, Brendan M. Weiss, Jeffrey Finklestein, Irina Kulikovskaya, Sanjoy K. Sinha, Shari S. Kronsberg, Minnal Gupta, Sarah Bond, Luca Melchiori, Joanna E. Brewer, Alan Bennett, Andrew B. Gerry, Nicholas J. Pumphrey, Daniel Williams, Helen K Tayton- Martin, Lilliam Ribeiro, Tom Holdich, Saul Yanovich, Nancy M. Hardy, Jean A. Yared, Naseem Kerr, Sunita Philip, Sandra Westphal, Don L. Siegel, Bruce L. Levine, Bent K. Jakobsen, Michael Kalos, Carl H. June
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer, J. Joseph Melenhorst, Simon F. Lacey, Eric Lancaster, Dan T. Vogl, Brendan M. Weiss, Karen Dengel, Annemarie Nelson, Gabriela Plesa, Fang Chen, Megan M. Davis, Wei‐Ting Hwang, Regina M. Young, Jennifer L. Brogdon, Randi Isaacs, Iulian Pruteanu-Malinici, Don L. Siegel, Bruce L. Levine, Carl H. June, Michael C. Milone
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Zhaohui Zheng, Dan T. Vogl, Adam D. Cohen, Brendan M. Weiss, Karen Dengel, Naseem Kerr, Adam Bagg, Bruce L. Levine, Carl H. June, Edward A. Stadtmauer
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Ginna G. Laport, Bruce L. Levine, Edward A. Stadtmauer, Stephen J. Schuster, Selina M. Luger, Stephan A. Grupp, Nancy Bunin, Frank J. Strobl, Julio Cotte, Zhaohui Zheng, Brian Gregson, Patricia M. Rivers, Robert H. Vonderheide, David Liebowitz, David L. Porter, Carl H. June